Close

Dr Edward Parker

BA MSc PhD

Assistant Professor
in Vaccine Epidemiology

Room
367

LSHTM
Keppel Street
London
WC1E 7HT
United Kingdom

I completed a BA in Biological Sciences at Oxford University, an MSc in Laboratory Medicine at the University of Toronto, and a PhD in infectious disease epidemiology at Imperial College London.

Affiliations

Department of Clinical Research
Faculty of Infectious and Tropical Diseases
Department of Infectious Disease Epidemiology
Faculty of Epidemiology and Population Health

Centres

Vaccine Centre

Research

My work considers factors that drive variation in uptake and effectiveness of vaccines.

There are two branches to my current research at LSHTM. As co-lead of Theme 1 ('Making the most of real-world data') for the NIHR Health Protection Research Unit in Immunisation, I use electronic health records to understand factors associated with vaccine uptake, effectiveness, and impact in the UK.

I also have a role in the Department of Clinical Research, where my work focuses on the possible contribution of the microbiome to infant oral vaccine response in low- and middle-income countries.

I am interested in data visualisation, and led the development of an interactive mapping tool to help contextualise the COVID-19 outbreak as well as LSHTM's COVID-19 vaccine tracker, which launched in April 2020. In late 2021, I acted as a consultant for the COVID-19 Working Group of the WHO's Strategic Advisory Group of Experts on Immunization.

Popular science writing:

A rise in deaths from preventable diseases must not be part of Covid-19's legacy, The Guardian, April 2020

Coronavirus: who is at risk and how do we know? The Conversation, March 2020 (co-authored with Professor Beate Kampmann)

Coronavirus outbreak: a new mapping tool that lets you scroll through timeline, The Conversation, February 2020

Andy Serkis’s Breathe is a haunting reminder of the pre-vaccine era, The Conversation, October 2017 (reprinted by The Independent)

Salk's swansong: renaissance of the injected polio vaccine, Science-based Medicine, October 2014

Research Area
Systematic reviews
Vaccines
Immunisation
Neonatal health
Discipline
Immunology
Microbiology
Bioinformatics
Vaccinology
Disease and Health Conditions
Diarrhoeal diseases
Infectious disease
Coronavirus
Country
United Kingdom
Gambia
India
Malawi
Region
Euro area
South Asia
Sub-Saharan Africa (developing only)

Selected Publications

Safety, immunogenicity, and effectiveness of COVID-19 vaccines for pregnant persons: A protocol for systematic review and meta analysis.
Ciapponi A; Berrueta M; Ballivian J; Bardach A; Mazzoni A; Anderson S; Argento FJ; Bok K; Comandé D; Goucher E
2023
Medicine
Bias assessment of a test-negative design study of COVID-19 vaccine effectiveness used in national policymaking.
Graham S; Tessier E; Stowe J; Bernal JL; Parker EPK; Nitsch D; Miller E; Andrews N; Walker JL; McDonald HI
2023
Nature communications
Comparative effectiveness of BNT162b2 versus mRNA-1273 covid-19 vaccine boosting in England: matched cohort study in OpenSAFELY-TPP.
Hulme WJ; Horne EMF; Parker EPK; Keogh RH; Williamson EJ; Walker V; Palmer TM; Curtis HJ; Walker AJ; Andrews CD
2023
BMJ
Association Between Maternal Breastmilk Microbiota Composition and Rotavirus Vaccine Response in African, Asian, and European Infants: A Prospective Cohort Study.
Mandolo J; Parker EPK; Bronowski C; Sindhu KNC; Darby AC; Cunliffe NA; Kang G; Iturriza-Gómara M; Kamng'ona AW; Jere KC
2023
Journal of infectious diseases
Changes in COVID-19-related mortality across key demographic and clinical subgroups in England from 2020 to 2022: a retrospective cohort study using the OpenSAFELY platform.
Nab L; Parker EPK; Andrews CD; Hulme WJ; Fisher L; Morley J; Mehrkar A; MacKenna B; Inglesby P; Morton CE
2023
The Lancet Public health
Comparative effectiveness of two- and three-dose COVID-19 vaccination schedules involving AZD1222 and BNT162b2 in people with kidney disease: a linked OpenSAFELY and UK Renal Registry cohort study.
OpenSAFELY Collaborative; Parker EPK; Horne EMF; Hulme WJ; Tazare J; Zheng B; Carr EJ; Loud F; Lyon S; Mahalingasivam V
2023
The Lancet regional health. Europe
Effect of the 2022 COVID-19 booster vaccination campaign in 50 year olds in England: regression discontinuity analysis in OpenSAFELY
Schaffer A; Hulme W; Horne E; Parker E; Walker V; Stables C; Mehrkar A; Bacon SCJ; Bates C; Goldacre B
2023
medRxiv
See more Publications